Clinical Trials
105 trialsOHGW-ACP
Azienda USL Reggio Emilia - IRCCS
FEAD
Helse Stavanger HF
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma
Henan Cancer Hospital
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
Sheba Medical Center
ETCABIO
University Hospital, Angers
NexCAR19
Health Institutes of Turkey
EHCancer
Zagazig University
ACL ALL
ASL Lecce
Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression
Region Stockholm
Anti CD19 Gene Therapy for B-cell Lymphoma
Anhui Provincial Hospital
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Linperlisib Combined With Chidamide in Patients With PTCL
Henan Cancer Hospital
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
The Affiliated People's Hospital of Ningbo University
PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma
Henan Cancer Hospital
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
ALHERT
University Hospital, Angers
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
Tel-Aviv Sourasky Medical Center
EscrimHEMA
University Hospital, Angers
Efficacy of Propofol-Ketamine and Sevoflurane in Children Undergoing Magnetic Resonance Imaging
Kocaeli City Hospital
MSTH-CAR002
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Vastra Gotaland Region
ECAR01
Anhui Provincial Hospital
Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
DOBL
Tata Memorial Hospital
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia
National Institute of Pediatrics, Mexico
PTCy and ATG for MSD and MUD Transplants
Instituto Nacional de Cancer, Brazil
For Grade I and II Knee Meniscal Injuries Patients ,Glucosamine, Chondroitin and Some Herbs Extract Phonophoresis Will Be Used (A) Versus Placebo(B)
General Committee of Teaching Hospitals and Institutes, Egypt
G-CSF in NHL
Department of Medical Services Ministry of Public Health of Thailand
The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
Anhui Provincial Hospital
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
The Third Affiliated Hospital of Southern Medical University
AvR-CHOP
Austin Health
1stFLOR
Austin Health
Astragalus for Symptomatic Alleviation in High-grade Lymphoma
Bnai Zion Medical Center
TEAM
Sheba Medical Center
L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma
Henan Cancer Hospital
This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma
Henan Cancer Hospital
Evaluation of Axial Stability of Two Models of Intraocular Lenses in Patients With an Eye Length More Than 26 mm
The S.N. Fyodorov Eye Microsurgery State Institution
RaDD
Austin Health
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Anhui Provincial Hospital
RAT-HEMATO
University Hospital, Angers
The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)
Henan Cancer Hospital
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research
Anhui Provincial Hospital
QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Anhui Provincial Hospital
Go-CHOP as the Frontline Therapy for PTCL
Henan Cancer Hospital
Integrative Medicine in Lymphoma Survivors
Bnai Zion Medical Center
Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia.
Coordinación de Investigación en Salud, Mexico
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research
Anhui Provincial Hospital
Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma
Henan Cancer Hospital